132 related articles for article (PubMed ID: 3513527)
21. Guanfacine: effects of long-term treatment and withdrawal.
Reid JL; Zamboulis C; Hamilton CA
Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):183S-188S. PubMed ID: 6994774
[TBL] [Abstract][Full Text] [Related]
22. Improved exercise performance of hypertensive patients treated with guanfacine (Estulic Sandoz).
Bazika V
Cor Vasa; 1987; 29(4 Suppl 1):42-5. PubMed ID: 3315450
[TBL] [Abstract][Full Text] [Related]
23. Improvement of glucose tolerance in hypertensive diabetic patients treated with guanfacine one year.
Hauger-Klevene JH; Scornavacchi JC
Eur J Clin Pharmacol; 1985; 29(4):391-3. PubMed ID: 3912183
[TBL] [Abstract][Full Text] [Related]
24. Clonidine and guanfacine in hypertension.
Jain AK; Hiremath A; Michael R; Ryan JR; McMahon FG
Clin Pharmacol Ther; 1985 Mar; 37(3):271-6. PubMed ID: 3882307
[TBL] [Abstract][Full Text] [Related]
25. Hemodynamic effects of guanfacine in essential hypertension.
Feldstein CA; Cohen AA; Sabaris RP; Burucúa JE
Clin Ther; 1984; 6(3):325-34. PubMed ID: 6373009
[TBL] [Abstract][Full Text] [Related]
26. Antihypertensive therapy with guanfacine induces elevated plasma growth hormone levels in diabetic patients.
Coves MJ; Gomis R; Casamitjana R; Lienas V; Vilaradell E
J Med; 1989; 20(3-4):291-6. PubMed ID: 2572660
[TBL] [Abstract][Full Text] [Related]
27. Guanfacine as monotherapy for systemic hypertension.
Fillingim JM; Blackshear JL; Strauss A; Strauss M
Am J Cardiol; 1986 Mar; 57(9):50E-54E. PubMed ID: 3513531
[TBL] [Abstract][Full Text] [Related]
28. [Use of the hypotensive drug guanfacine in the treatment of patients with hypertension].
Kravchenko IG; Liashenko MM; Tarnakin AG; Chirkov SN
Kardiologiia; 1986 Mar; 26(3):41-5. PubMed ID: 3520085
[TBL] [Abstract][Full Text] [Related]
29. [Haemodynamic investigations with the new antihypertensive drug guanfacine (author's transl)].
Rosenthal J; Schäfer N; Rauh J; Raschig A
Dtsch Med Wochenschr; 1980 Nov; 105(48):1680-4. PubMed ID: 7002524
[TBL] [Abstract][Full Text] [Related]
30. Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.
Sorkin EM; Heel RC
Drugs; 1986 Apr; 31(4):301-36. PubMed ID: 3519177
[TBL] [Abstract][Full Text] [Related]
31. The effect of small doses of guanfacine (Estulic Sandoz) on the lipid levels and catecholamine excretion in patients with essential hypertension.
Balazovjech I; Skultétyová D; Mikulecký M; Kratochvíl'ová H
Cor Vasa; 1987; 29(4 Suppl 1):46-52. PubMed ID: 3315451
[TBL] [Abstract][Full Text] [Related]
32. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
[TBL] [Abstract][Full Text] [Related]
33. Antihypertensive effects and plasma levels of guanfacine in man.
Safar ME; Loria Y; Weiss YA; Boutier JR
J Clin Pharmacol; 1982; 22(8-9):385-90. PubMed ID: 6752213
[TBL] [Abstract][Full Text] [Related]
34. Withdrawal of guanfacine after long-term treatment in essential hypertension. Observations on blood pressure and plasma and urinary noradrenaline.
Zamboulis C; Reid JL
Eur J Clin Pharmacol; 1981 Jan; 19(1):19-24. PubMed ID: 7007059
[TBL] [Abstract][Full Text] [Related]
35. Guanfacine: a new centrally-acting antihypertensive agent.
Beevers DG; Bloxham CA; Walker JM
Pharmatherapeutica; 1981; 2(8):513-6. PubMed ID: 7019931
[TBL] [Abstract][Full Text] [Related]
36. [Treatment of arterial hypertension with a single daily dose of guanfacine].
Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
[No Abstract] [Full Text] [Related]
37. Long-term clinical experience with guanfacine.
Fetkovská N; Brimichová G; Sebeková K; Dzúrik R
Cor Vasa; 1987; 29(4 Suppl 1):23-9. PubMed ID: 3315447
[TBL] [Abstract][Full Text] [Related]
38. Long-term antihypertensive therapy with guanfacine.
Szám I; Holló J
Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):388-92. PubMed ID: 6749702
[TBL] [Abstract][Full Text] [Related]
39. Comparison of antihypertensive activity and tolerability of guanfacine and methyldopa.
Malini PL; Strocchi E; Ambrosioni E; Magnani B
Int J Clin Pharmacol Res; 1983; 3(1):35-9. PubMed ID: 6384071
[TBL] [Abstract][Full Text] [Related]
40. Improved glucose tolerance after guanfacine treatment in hypertensive diabetic (type II) patients: one year follow up.
Hauger-Klevene JH; Scornavacchi JC
Horm Metab Res; 1985 Nov; 17(11):613-4. PubMed ID: 3908271
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
